Anti-ADAM9 antibody [EPR21924-164]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal ADAM9 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 5 publications.
View Alternative Names
KIAA0021, MCMP, MDC9, MLTNG, ADAM9, Disintegrin and metalloproteinase domain-containing protein 9, ADAM 9, Cellular disintegrin-related protein, Meltrin-gamma, Metalloprotease/disintegrin/cysteine-rich protein 9, Myeloma cell metalloproteinase
- IP
Supplier Data
Immunoprecipitation - Anti-ADAM9 antibody [EPR21924-164] (AB218242)
ADAM9 was immunoprecipitated from 0.35 mg HeLa (human cervix adenocarcinoma cell) whole cell lysate with ab218242 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab218242 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1/5000 dilution.
Lane 1 : HeLa whole cell lysate 10μg (input).
Lane 2 : ab218242 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab218242 in HeLa whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 minutes.
The conformational epitope maybe changed after cleavage and this antibody has better affinity to the pro-form.
The molecular mass observed is consistent with what has been described in the literature (PMID 29118335; PMID : 12767059; PMID : 20736367).
All lanes:
Immunoprecipitation - Anti-ADAM9 antibody [EPR21924-164] (ab218242)
Predicted band size: 70 kDa,85 kDa,91 kDa
Observed band size: 100 kDa,75 kDa
false
- WB
Supplier Data
Western blot - Anti-ADAM9 antibody [EPR21924-164] (AB218242)
Blocking/diluting buffer and concentration : 5% NFDM/TBST
Exposure times :
Lanes 1-5 : 3 minutes
Lane 6 : 48 seconds
Lane 7 : 114 seconds
The molecular mass observed is consistent with what has been described in the literature (PMID 29118335; PMID : 12767059; PMID : 20736367).
We recommend that customers avoid boiling their samples to prevent protein aggregation.
All lanes:
Western blot - Anti-ADAM9 antibody [EPR21924-164] (ab218242) at 1/1000 dilution
Lane 1:
HepG2 (human hepatocellular carcinoma epithelial cell), whole cell lysate at 10 µg
Lane 2:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 10 µg
Lane 3:
WI-38 (human fetal lung fibroblast), whole cell lysate at 10 µg
Lane 4:
MCF7 (human breast adenocarcinoma epithelial cell), whole cell lysate at 10 µg
Lane 5:
U-87 MG (human glioblastoma-astrocytoma epithelial cell), whole cell lysate at 10 µg
Lane 6:
A549 (human lung carcinoma epithelial cell), whole cell lysate at 10 µg
Lane 7:
A431 (human epidermoid carcinoma epithelial cell), whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 91 kDa
Observed band size: 100 kDa,75 kDa
false
- WB
Lab
Western blot - Anti-ADAM9 antibody [EPR21924-164] (AB218242)
Lanes 1-3 : Merged signal (red and green). Green - ab218242 observed at 100,75 kDa. Red - loading control ab8245 observed at 36 kDa.
ab218242 Anti-ADAM9 antibody [EPR21924-164] was shown to specifically react with ADAM9 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265484 (knockout cell lysate ab257814) was used. Wild-type and ADAM9 knockout samples were subjected to SDS-PAGE. ab218242 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-ADAM9 antibody [EPR21924-164] (ab218242) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
ADAM9 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human ADAM9 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-adam9-knockout-hela-cell-line-ab265484'>ab265484</a>)
Lane 3:
HepG2 cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 91 kDa
Observed band size: 100 kDa,75 kDa
false
Related conjugates and formulations (1)
-
Anti-ADAM9 antibody [EPR21924-164] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ADAM9 participates in numerous essential cellular functions particularly in cell surface protein shedding and proteolytic activities. It is part of the protease complex involved in shedding epidermal growth factor receptor (EGFR) ligands. This action impacts cell signaling pathways that contribute to processes such as cell proliferation migration and invasion.
Pathways
Many studies link ADAM9 to pathways involving cell signal modulation and extracellular matrix remodeling. It participates in the EGFR signaling pathway significantly affecting cell behavior. ADAM9 interacts with other proteins such as integrins which facilitate changes in cell dynamics and communication.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular medicine 56: PubMed40999989
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of medical sciences 22:630-640 PubMed39898241
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science translational medicine 14:eabj7521 PubMed34698500
2022
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 14:2773-2787 PubMed33907420
2021
Applications
Unspecified application
Species
Unspecified reactive species
American journal of translational research 12:5525-5537 PubMed33042435
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com